Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Nitric Oxide. 2014 Oct 27;48:22–30. doi: 10.1016/j.niox.2014.10.007

Table 3.

Secondary outcome variables at baseline, Iso-time exercise and the end of exercise during the beetroot and placebo trials

Beetroot Placebo P
Heart Rate, bpm
 Rest 70 [62, 78] 69 [61, 77] 0.707
 Iso-time 110 [97, 123] 112 [99, 124] 0.300
 End Exercise 117 [100, 137] 123[103, 142] 0.475
Oxygen Consumption, ml*kg−1*min−1
 Rest 4.1 [3.3, 4.8] 4.0 [3.4, 4.6] 0.925
*Iso-time 14.1 + 5.4 13.4 + 5.5 0.099
 End Exercise 14.1 [11.8, 16.4] 14.4[12.4, 16.4] 0.436
Systolic Blood Pressure, mmHg
 Rest 124.3 [115.2, 133.4] 132.5[121.7, 143.4] 0.019
 Iso-time 160.1 [147.8, 172.5] 167.1 151.7, 182.4] 0.137
 End Exercise 164.0 [147.5, 180.5] 170.4 [153.9, 186.9] 0.296
Diastolic Blood Pressure, mmHg
 Rest 77.2 [71.8, 82.6] 80.9 [75.3, 86.6] 0.065
 Iso-time 79.9 [72.8, 86.9] 86.3 [79.6, 92.9] 0.001
 End Exercise 80.0 [72.9, 87.1] 85.6 [79.7, 91.5] 0.008
Arterial O2 Saturation, %
 Rest 95.4 [94.4, 96.5] 95.4 [94.2, 96.7] 1.0
 Iso-time 95.1 [93.9, 96.2] 95.1[94.0, 96.2] 0.895
 End Exercise 95.2 [93.9, 96.5] 95.2 [94.1, 96.3] 1.0
*

Non-normally distributed variables. Normally distributed va ues are presented as means and [95% confidence intervals]. Non-normally distributed variables are presented as medians and interquartile ranges.